Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

[Thalidomide as immunomodulatory drug: pharmacological actions and its indications].

Yasui K.

Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(5):229-33. Review. Japanese.

2.

Thalidomide as an immunotherapeutic agent: the effects on neutrophil-mediated inflammation.

Yasui K, Kobayashi N, Yamazaki T, Agematsu K.

Curr Pharm Des. 2005;11(3):395-401. Review.

PMID:
15723633
3.

Thalidomide: current and potential clinical applications.

Calabrese L, Fleischer AB.

Am J Med. 2000 Apr 15;108(6):487-95. Review.

PMID:
10781782
4.

Potential novel uses of thalidomide: focus on palliative care.

Peuckmann V, Fisch M, Bruera E.

Drugs. 2000 Aug;60(2):273-92. Review.

PMID:
10983733
5.

Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B.

Rowland TL, McHugh SM, Deighton J, Ewan PW, Dearman RJ, Kimber I.

Int Immunopharmacol. 2001 Jan;1(1):49-61.

PMID:
11367517
6.

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.

Tseng S, Pak G, Washenik K, Pomeranz MK, Shupack JL.

J Am Acad Dermatol. 1996 Dec;35(6):969-79. Review.

PMID:
8959957
8.

Theoretical basis for the activity of thalidomide.

Meierhofer C, Dunzendorfer S, Wiedermann CJ.

BioDrugs. 2001;15(10):681-703. Review.

PMID:
11604049
9.

Thalidomide: an antineoplastic agent.

Amato RJ.

Curr Oncol Rep. 2002 Jan;4(1):56-62. Review.

PMID:
11734114
10.

Thalidomide: a re-look.

Grover JK, Vats V, Gopalakrishna R, Ramam M.

Natl Med J India. 2000 May-Jun;13(3):132-41. Review.

PMID:
11558112
11.

Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.

Haslett PA, Roche P, Butlin CR, Macdonald M, Shrestha N, Manandhar R, Lemaster J, Hawksworth R, Shah M, Lubinsky AS, Albert M, Worley J, Kaplan G.

J Infect Dis. 2005 Dec 15;192(12):2045-53. Epub 2005 Nov 10.

PMID:
16288366
12.

[Should thalidomide be rehabilitated?].

Belaube P, Garcin G, Marchand JP, Privat Y.

Sem Hop. 1983 Dec 8;59(45):3101-4. French.

PMID:
6320398
13.

[The revival of thalidomide: an old drug with new indications].

Laffitte E.

Rev Prat. 2006 Nov 30;56(18):1977-83. Review. French.

PMID:
17274497
14.

Thalidomide revisited: pharmacology and clinical applications.

Calabrese L, Resztak K.

Expert Opin Investig Drugs. 1998 Dec;7(12):2043-60.

PMID:
15991946
15.

[Thalidomide: new uses for an old drug].

Wu KL, Sonneveld P.

Ned Tijdschr Geneeskd. 2002 Aug 3;146(31):1438-41. Review. Dutch.

PMID:
12190008
16.

Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.

Ladizinski B, Shannon EJ, Sanchez MR, Levis WR.

J Drugs Dermatol. 2010 Jul;9(7):814-26. Review.

PMID:
20677538
17.

[Novel potential uses of thalidomide in the management of pain? A review of the literature].

Peuckmann V, Strumpf M, Zenz M, Bruera E.

Schmerz. 2003 Jun;17(3):204-10. Review. German.

PMID:
12789488
18.

A review of thalidomide's history and current dermatological applications.

Perri AJ 3rd, Hsu S.

Dermatol Online J. 2003 Aug;9(3):5. Review.

19.

The promise of thalidomide: evolving indications.

Joglekar S, Levin M.

Drugs Today (Barc). 2004 Mar;40(3):197-204. Review.

PMID:
15148528
20.

Thalidomide for erythema nodosum leprosum and other applications.

Okafor MC.

Pharmacotherapy. 2003 Apr;23(4):481-93. Review.

PMID:
12680478

Supplemental Content

Support Center